var data={"title":"Treatment protocols for castration-resistant prostate cancer","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Treatment protocols for castration-resistant prostate cancer</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-castration-resistant-prostate-cancer/contributors\" class=\"contributor contributor_credentials\">Tim Brenner, PharmD, BCOP</a></dd><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-castration-resistant-prostate-cancer/contributors\" class=\"contributor contributor_credentials\">Shrina Duggal, PharmD, BCOP</a></dd><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-castration-resistant-prostate-cancer/contributors\" class=\"contributor contributor_credentials\">Jim Natale, PharmD, BCOP</a></dd><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-castration-resistant-prostate-cancer/contributors\" class=\"contributor contributor_credentials\">Scott M Wirth, PharmD, BCOP</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-castration-resistant-prostate-cancer/contributors\" class=\"contributor contributor_credentials\">John W Mucenski, PharmD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-castration-resistant-prostate-cancer/contributors\" class=\"contributor contributor_credentials\">Michael E Ross, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-castration-resistant-prostate-cancer/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Aug 02, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H6926555\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following material represents a subset of chemotherapy regimens that are used for the treatment of patients with prostate cancer. <strong>This is</strong> <strong>not an exhaustive list</strong>; it includes regimens that are considered by the authors and editors to be commonly used and important for the care of patients with prostate cancer. Additional regimens may be added over time, particularly as treatment for prostate cancer evolves.</p><p>This topic review is intended to provide only a listing of chemotherapy regimens. It does not address the appropriate context for use of these regimens in the care of patients with prostate cancer. Clinicians should refer to the individual disease-oriented topic reviews that discuss the use of these protocols in appropriate clinical situations:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=overview-of-the-treatment-of-disseminated-castration-sensitive-prostate-cancer\" class=\"medical medical_review\">&quot;Overview of the treatment of disseminated castration-sensitive prostate cancer&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=chemotherapy-in-castration-resistant-prostate-cancer\" class=\"medical medical_review\">&quot;Chemotherapy in castration-resistant prostate cancer&quot;</a>.)</p><p/><p>These tables are provided as examples of how to administer these regimens; there may be other acceptable methods. All chemotherapy regimens must be administered by clinicians who are trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.</p><p class=\"headingAnchor\" id=\"H119855717\"><span class=\"h1\">REGIMENS</span></p><p class=\"headingAnchor\" id=\"H932475884\"><span class=\"h2\">Cabazitaxel and prednisone</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(<a href=\"image.htm?imageKey=ONC%2F82196\" class=\"graphic graphic_table graphicRef82196 \">table 1</a>)</p><p class=\"headingAnchor\" id=\"H932475909\"><span class=\"h2\">Docetaxel and prednisone</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(<a href=\"image.htm?imageKey=ONC%2F57477\" class=\"graphic graphic_table graphicRef57477 \">table 2</a>)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"topicVersionRevision\">Topic 85678 Version 7.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li><a href=\"#H6926555\" id=\"outline-link-H6926555\">INTRODUCTION</a></li><li><a href=\"#H119855717\" id=\"outline-link-H119855717\">REGIMENS</a><ul><li><a href=\"#H932475884\" id=\"outline-link-H932475884\">Cabazitaxel and prednisone</a></li><li><a href=\"#H932475909\" id=\"outline-link-H932475909\">Docetaxel and prednisone</a></li></ul></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ONC/85678|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ONC/82196\" class=\"graphic graphic_table\">- Cabazitaxel and prednisone for prostate cancer</a></li><li><a href=\"image.htm?imageKey=ONC/57477\" class=\"graphic graphic_table\">- Docetaxel and prednisone for prostate cancer</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=chemotherapy-in-castration-resistant-prostate-cancer\" class=\"medical medical_review\">Chemotherapy in castration-resistant prostate cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-treatment-of-disseminated-castration-sensitive-prostate-cancer\" class=\"medical medical_review\">Overview of the treatment of disseminated castration-sensitive prostate cancer</a></li></ul></div></div>","javascript":null}